NC
SGRY icon

NinePointTwo Capital’s Surgery Partners SGRY Stock Holding History

NinePointTwo Capital’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,948
Closed -$326K – 254
2022
Q3 		$326K Buy
+13,948
New +$445K 0.13% 80

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NinePointTwo Capital's SGRY Position: Q4 2022 in Review

NinePointTwo Capital sold out of Surgery Partners (SGRY) in Q4 2022, closing a stake of 13,948 shares — an estimated $326K sold.

NinePointTwo Capital first reported a position in SGRY in Q3 2022 and held it in 1 quarter. The position peaked at $326K in Q3 2022. 161 funds tracked by Wall St. Rank hold SGRY as of Q4 2022.

  • NinePointTwo Capital reported no remaining Surgery Partners position as of Q4 2022 after selling out during the quarter.
  • NinePointTwo Capital sold 13,948 Surgery Partners shares in Q4 2022, an estimated $326K.
  • NinePointTwo Capital first reported a position in Surgery Partners in Q3 2022 and held it in 1 quarter.
  • NinePointTwo Capital's Surgery Partners position peaked at $326K in Q3 2022.
  • 161 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2022.

Based on NinePointTwo Capital's 13F filing for Q4 2022, filed 14 Feb 2023.